Concepedia

Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine

Mark S. Riddle, Robert W. Kaminski, Carlos Williams, Chad K. Porter, Shahida Baqar, Alexis A. Kordis, Theron Gilliland, Joyce A. Lapa, Melissa Coughlin, Chris Soltis,

Vaccine · 2011 · 79 citations · 21 references

DOI

Concepts

References

21

Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Karen L. Kotloff, Jonathan P. Winickoff, B Ivanoff et al. · PubMed · 1999 · 1.3K citations · Full text

, , +17

Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells

Robert Ménard, Philippe Sansonetti, Claude Parsot · Journal of Bacteriology · 1993 · 718 citations · Full text

, , +17

The Tripartite Type III Secreton of <i>Shigella flexneri</i> Inserts Ipab and Ipac into Host Membranes

Ariel Blocker, Pierre Gounon, Éric Larquet et al. · The Journal of Cell Biology · 1999 · 492 citations · Full text

, , +17

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

M L Clements, Robert F. Betts, E L Tierney et al. · Journal of Clinical Microbiology · 1986 · 435 citations · Full text

, , +17

Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals

Laurel Yong-Hwa Lee, Lien Anh Ha, Cameron P. Simmons et al. · Journal of Clinical Investigation · 2008 · 427 citations · Full text

, , +17